Trials / Recruiting
RecruitingNCT06676007
A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy
A Multicenter Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Sichuan Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To observe of the efficacy and safety of early initiation of budesonide enteric coated capsules in the treatment of primary IgA nephropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Gd-IgA1 test | collect and test Gd-IgA1 test in enrolled subjects |
Timeline
- Start date
- 2024-10-30
- Primary completion
- 2026-12-31
- Completion
- 2027-06-30
- First posted
- 2024-11-06
- Last updated
- 2026-01-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06676007. Inclusion in this directory is not an endorsement.